GaviLyte-H and Bisacodyl

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 43386-071
  • Package NDC 43386-071-83
  • Application number ANDA202217
  • SPL ID c34cfe17-96c2-4f07-8a2d-74bc84e61fb4
  • SPL set ID 78fe1c29-e22a-4615-a2f9-a61cd4eb38a3
  • RxCUI 308753
  • RxCUI 1000479
  • RxCUI 1718983
  • RxCUI 1718990
  • RxCUI 1718991

What the source publishes

Labeler
Lupin Pharmaceuticals, Inc.
Active ingredients
Polyethylene Glycol 3350, Sodium Chloride, Sodium Bicarbonate, Potassium Chloride and Bisacodyl Delayed-release Tablet
Form
KIT
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:43386-071_c34cfe17-96c2-4f07-8a2d-74bc84e61fb4
{
  "name": "GaviLyte-H and Bisacodyl",
  "splId": "c34cfe17-96c2-4f07-8a2d-74bc84e61fb4",
  "labels": [
    {
      "setId": "78fe1c29-e22a-4615-a2f9-a61cd4eb38a3",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=78fe1c29-e22a-4615-a2f9-a61cd4eb38a3",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=78fe1c29-e22a-4615-a2f9-a61cd4eb38a3"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Lupin Pharmaceuticals, Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "1 KIT in 1 KIT (43386-071-83)  *  1 TABLET, DELAYED RELEASE in 1 BLISTER PACK (43386-010-61)  *  2 L in 1 BOTTLE (43386-070-17)",
      "package_ndc": "43386-071-83",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20150421"
    }
  ],
  "productId": "43386-071_c34cfe17-96c2-4f07-8a2d-74bc84e61fb4",
  "useDomain": "unknown",
  "dosageForm": "KIT",
  "productNdc": "43386-071",
  "deaSchedule": null,
  "genericName": "Polyethylene Glycol 3350, Sodium Chloride, Sodium Bicarbonate, Potassium Chloride and Bisacodyl Delayed-release Tablet",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [],
  "applicationNumber": "ANDA202217",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20150421",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "upc": [
      "0343386205028"
    ],
    "rxcui": [
      "308753",
      "1000479",
      "1718983",
      "1718990",
      "1718991"
    ],
    "spl_set_id": [
      "78fe1c29-e22a-4615-a2f9-a61cd4eb38a3"
    ],
    "manufacturer_name": [
      "Lupin Pharmaceuticals, Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:43386-071_c34cfe17-96c2-4f07-8a2d-74bc84e61fb4"